NFE2L2 and cancer: Importantly, since Wogonin has been shown to induce anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/NRF2 pathways in human osteoarthritis chondrocytes [322], it is possible that this compound might regulate the NRF2 function in two opposite directions depending on the context of normal or cancer cells.